Neurocrine Bioscience buy Needham & Company LLC
Start price
22.09.25
/
50%
€124.40
Target price
22.09.26
€144.89
Performance (%)
-11.62%
Price
10.04.26
€109.95
Summary
This prediction is currently active. The price of Neurocrine Bioscience has decreased since the start of the prediction. Compared to the start price this results in a performance of -11.62%. This prediction currently runs until 22.09.26. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | -3.637% | -3.637% |
| iShares Core DAX® | 2,55 % | -0,11 % |
| iShares Nasdaq 100 | 2,74 % | -0,47 % |
| iShares Nikkei 225® | 6,58 % | 3,22 % |
| iShares S&P 500 | 1,93 % | -0,52 % |
Comments by Needham___Company_LL for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences (NASDAQ:NBIX) had its price target raised by analysts at Needham & Company LLC from $161.00 to $170.00. They now have a "buy" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Needham___Company_LL for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€113.60
06.04.26
06.04.26
€160.60
06.04.27
06.04.27
-1.76%
10.04.26
10.04.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€112.35
06.05.25
06.05.25
€123.07
06.05.26
06.05.26
-2.14%
10.04.26
10.04.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€86.30
15.04.25
15.04.25
€121.87
15.04.26
15.04.26
27.40%
10.04.26
10.04.26